Burning Rock Biotech Ltd
NASDAQ:BNR
Burning Rock Biotech Ltd
Net Income (Common)
Burning Rock Biotech Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
Net Income (Common)
¥-971.2m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Net Income (Common)
¥-13.6B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Net Income (Common)
¥-2.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Net Income (Common)
¥4.7B
|
CAGR 3-Years
183%
|
CAGR 5-Years
99%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Net Income (Common)
¥8.5B
|
CAGR 3-Years
40%
|
CAGR 5-Years
47%
|
CAGR 10-Years
45%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Net Income (Common)
¥1.3B
|
CAGR 3-Years
61%
|
CAGR 5-Years
73%
|
CAGR 10-Years
N/A
|
See Also
What is Burning Rock Biotech Ltd's Net Income (Common)?
Net Income (Common)
-971.2m
CNY
Based on the financial report for Dec 31, 2022, Burning Rock Biotech Ltd's Net Income (Common) amounts to -971.2m CNY.
What is Burning Rock Biotech Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-39%
Over the last year, the Net Income (Common) growth was -22%. The average annual Net Income (Common) growth rates for Burning Rock Biotech Ltd have been -43% over the past three years , -39% over the past five years .